BCRX·09058V103·US·equity·Healthcare - Drug Manufacturers - Specialty & Generic-13D/G
BCRX (BIOCRYST PHARMACEUTICALS INC) is held by 149 institutional investors as of Q1 2026. Largest holders: BlackRock, Inc. ($215.6M), RA CAPITAL MANAGEMENT, L.P. ($150.7M), STATE STREET CORP ($116.2M). Net institutional sentiment: Mixed.
See how BCRX's score breaks down across 4 SEC sources
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer